BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rialon KL, Murillo R, Fevurly RD, Kulungowski AM, Christison-Lagay ER, Zurakowski D, Kozakewich HP, Alomari AI, Fishman SJ. Risk factors for mortality in patients with multifocal and diffuse hepatic hemangiomas. J Pediatr Surg. 2015;50:837-841. [PMID: 25783331 DOI: 10.1016/j.jpedsurg.2014.09.056] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 López-gutiérrez J. Clinical and economic impact of surgery for treating infantile hemangiomas in the era of propranolol: overview of single-center experience from La Paz Hospital, Madrid. Eur J Pediatr 2019;178:1-6. [DOI: 10.1007/s00431-018-3290-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
2 Al Tasseh F, El-Khansa M, Abd O, Abdel Khalek A, El-Rifai N. Diffuse hepatic hemangioma with single cutaneous hemangioma: an alerting occurrence. Clin Case Rep 2017;5:887-90. [PMID: 28588832 DOI: 10.1002/ccr3.963] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Iacobas I, Phung TL, Adams DM, Trenor CC 3rd, Blei F, Fishman DS, Hammill A, Masand PM, Fishman SJ. Guidance Document for Hepatic Hemangioma (Infantile and Congenital) Evaluation and Monitoring. J Pediatr 2018; 203: 294-300. e2. [PMID: 30244993 DOI: 10.1016/j.jpeds.2018.08.012] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 8.8] [Reference Citation Analysis]
4 Yang K, Peng S, Chen L, Chen S, Ji Y. Efficacy of propranolol treatment in infantile hepatic haemangioma. J Paediatr Child Health 2019;55:1194-200. [DOI: 10.1111/jpc.14375] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Yang K, Feng L, Chen S, Ji Y. Progressive infantile hepatic hemangioma not responding to propranolol. J Dermatol 2019;46:e275-6. [PMID: 30821839 DOI: 10.1111/1346-8138.14833] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Fuchs J, Warmann SW, Urla C, Schäfer JF, Schmidt A. Management of benign liver tumors. Semin Pediatr Surg 2020;29:150941. [PMID: 32861445 DOI: 10.1016/j.sempedsurg.2020.150941] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Li K, Wang Z, Liu Y, Yao W, Gong Y, Xiao X. Fine clinical differences between patients with multifocal and diffuse hepatic hemangiomas. Journal of Pediatric Surgery 2016;51:2086-90. [DOI: 10.1016/j.jpedsurg.2016.09.045] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
8 Lucas B, Ravishankar S, Pateva I. Pediatric Primary Hepatic Tumors: Diagnostic Considerations. Diagnostics (Basel) 2021;11:333. [PMID: 33670452 DOI: 10.3390/diagnostics11020333] [Reference Citation Analysis]
9 Varrasso G, Schiavetti A, Lanciotti S, Sapio M, Ferrara E, De Grazia A, Clerico A. Propranolol as first-line treatment for life-threatening diffuse infantile hepatic hemangioma: A case report: Varrasso et al. Hepatology 2017;66:283-5. [DOI: 10.1002/hep.29028] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
10 Hinen HB, Trenor CC 3rd, Wine Lee L. Childhood Vascular Tumors. Front Pediatr 2020;8:573023. [PMID: 33194900 DOI: 10.3389/fped.2020.573023] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Gnarra M, Behr G, Kitajewski A, Wu JK, Anupindi SA, Shawber CJ, Zavras N, Schizas D, Salakos C, Economopoulos KP. History of the infantile hepatic hemangioma: From imaging to generating a differential diagnosis. World J Clin Pediatr 2016; 5(3): 273-280 [PMID: 27610342 DOI: 10.5409/wjcp.v5.i3.273] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
12 Mcguire A, Fernandez-pineda I, Fishman SJ, Dickie BH. Pediatric hepatic vascular tumors. Seminars in Pediatric Surgery 2020;29:150970. [DOI: 10.1016/j.sempedsurg.2020.150970] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Valdebran M, Wine Lee L. Hemangioma-related syndromes. Current Opinion in Pediatrics 2020;32:498-505. [DOI: 10.1097/mop.0000000000000925] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Ji Y, Chen S, Xiang B, Xu Z, Jiang X, Liu X, Wang Q, Lu G, Yang L. Clinical features and management of multifocal hepatic hemangiomas in children: a retrospective study. Sci Rep 2016;6:31744. [PMID: 27530723 DOI: 10.1038/srep31744] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
15 Rodrigues A, Forno A, Costa E, Berenguer A, Pilar C, Loureiro R, Rufino D, Barros A, Teixeira F. Diffuse infantile hepatic haemangioma-how to manage an incidental but potentially lethal finding. Oxf Med Case Reports 2018;2018:omy054. [PMID: 30151220 DOI: 10.1093/omcr/omy054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Warren D, Diaz L, Levy M. Diffuse Hepatic Hemangiomas Successfully Treated Using Sirolimus and High-Dose Propranolol. Pediatr Dermatol 2017;34:e286-7. [DOI: 10.1111/pde.13219] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
17 Adams DM, Brandão LR, Peterman CM, Gupta A, Patel M, Fishman S, Trenor CC. Vascular anomaly cases for the pediatric hematologist oncologists-An interdisciplinary review. Pediatr Blood Cancer 2018;65:e26716. [DOI: 10.1002/pbc.26716] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
18 Potanos KM, Hodgkinson N, Fullington NM, Narla A, Albritton K, Kozakewich H, Kim HB. Long term survival in pediatric hepatic angiosarcoma (PHAS): A case report and review of the literature. Journal of Pediatric Surgery Case Reports 2015;3:410-3. [DOI: 10.1016/j.epsc.2015.08.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
19 Schooler GR, Hull NC, Lee EY. Hepatobiliary MRI Contrast Agents: Pattern Recognition Approach to Pediatric Focal Hepatic Lesions. American Journal of Roentgenology 2020;214:976-86. [DOI: 10.2214/ajr.19.22239] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]